Document ID: FDA-2015-N-1196-0002
Agency: fda
Document Type: Notice
Title: List of Bulk Drug Substances That May Be Used by an Outsourcing Facility To Compound Drugs for Use in Animals; Request for Nominations; Correction
Posted Date: 2015-06-25T04:00Z

[Federal Register Volume 80, Number 122 (Thursday, June 25, 2015)]
[Notices]
[Page 36543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15558]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-1196]

List of Bulk Drug Substances That May Be Used by an Outsourcing 
Facility To Compound Drugs for Use in Animals; Request for Nominations; 
Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a notice 
entitled ``List of Bulk Drug Substances That May Be Used by an 
Outsourcing Facility to Compound Drugs for Use in Animals; Request for 
Nominations'' that appeared in the Federal Register of May 19, 2015 (80 
FR 28622). The document announced the intention to develop a list of 
bulk drug substances that may be used by outsourcing facilities 
registered under the Federal Food, Drug, and Cosmetic Act (the FD&C 
Act) to compound animal drugs, in accordance with FDA's draft guidance 
for industry #230, ``Compounding Animal Drugs from Bulk Drug 
Substances.'' The document was published with an incorrect docket 
number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and 
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, May 19, 
2015, in FR Doc. 2015-11983, the following correction is made:
    1. On page 28622, in the second column, in the ADDRESSES section of 
the document, under Instructions, ``Docket No. FDA-2013-N-1524'' is 
corrected to read ``Docket No. FDA-2015-N-1196''.

    Dated: June 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-15558 Filed 6-24-15; 8:45 am]
 BILLING CODE 4164-01-P